Maxime Dougados

47.9k total citations · 11 hit papers
395 papers, 24.8k citations indexed

About

Maxime Dougados is a scholar working on Rheumatology, Hematology and Surgery. According to data from OpenAlex, Maxime Dougados has authored 395 papers receiving a total of 24.8k indexed citations (citations by other indexed papers that have themselves been cited), including 328 papers in Rheumatology, 67 papers in Hematology and 58 papers in Surgery. Recurrent topics in Maxime Dougados's work include Rheumatoid Arthritis Research and Therapies (217 papers), Spondyloarthritis Studies and Treatments (101 papers) and Osteoarthritis Treatment and Mechanisms (78 papers). Maxime Dougados is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (217 papers), Spondyloarthritis Studies and Treatments (101 papers) and Osteoarthritis Treatment and Mechanisms (78 papers). Maxime Dougados collaborates with scholars based in France, United States and Netherlands. Maxime Dougados's co-authors include B Amor, Dominique Baeten, Désirée van der Heijde, X Ayral, Laure Gossec, Philippe Ravaud, Paul Emery, Robert Landewé, Joachim Sieper and Bernard Combe and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Immunology.

In The Last Decade

Maxime Dougados

379 papers receiving 23.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks

2006 1.3k citations Maxime Dougados et al. profile →
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

2010 1.1k citations Maxime Dougados, Filip Van den Bosch et al. Annals of the Rheumatic Diseases profile →
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

2005 920 citations Maxime Dougados et al. profile →
Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

2003 807 citations Maxime Dougados et al. profile →
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

2008 720 citations Maxime Dougados, Désirée van der Heijde et al. Annals of the Rheumatic Diseases profile →
Spondyloarthritis

2011 574 citations Maxime Dougados, Dominique Baeten The Lancet profile →
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

2006 566 citations Bernard Combe, Maxime Dougados et al. Annals of the Rheumatic Diseases profile →
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial

2005 500 citations Désirée van der Heijde, Andrei Călin et al. profile →
Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis – results of a 1 year longitudinal arthroscopic study in 422 patients

2005 475 citations Maxime Dougados et al. Osteoarthritis and Cartilage profile →
[Criteria of the classification of spondylarthropathies].

1990 424 citations Maxime Dougados et al. profile →
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study

2012 316 citations Florence Tubach, Philippe Ravaud et al. Arthritis Care & Research profile →

Peers

Countries citing papers authored by Maxime Dougados

Since Specialization

Citations

This map shows the geographic impact of Maxime Dougados's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Dougados with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Dougados more than expected).

Fields of papers citing papers by Maxime Dougados

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Dougados. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Dougados. The network helps show where Maxime Dougados may publish in the future.

Co-authorship network of co-authors of Maxime Dougados

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Dougados. A scholar is included among the top collaborators of Maxime Dougados based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Dougados. Maxime Dougados is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The history of ankylosing spondylitis/axial spondyloarthritis – what is the driving force of new knowledge? 2024 ·Seminars in Arthritis and Rheumatism ·Jürgen Braun, J. Sieper, Maxime Dougados	1
2	The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis – methodology and baseline characteristics of the population 2021 ·Joint Bone Spine ·Jérémie Sellam, E. Maheu, M.D. Crema, (unknown), Alice Courties, Sophie Tuffet, Alexandra Rousseau, Xavier Chevalier, Bernard Combe, Maxime Dougados, Bruno Fautrel, M. Kloppenburg, Jean‐Denis Laredo, Damien Lœuille, Anne Miquel, François Rannou, Pascal Richette, Tabassome Simon, Francis Bérenbaum	22
3	Metacarpophalangeal Joint Impairment in Hand Osteoarthritis and Its Association With Mechanical Factors: Results From the Digital Cohort Osteoarthritis Design Hand Osteoarthritis Cohort 2021 ·Arthritis Care & Research ·(unknown), Sophie Tuffet, M.D. Crema, Alexandra Rousseau, Pascal Richette, Maxime Dougados, Francis Bérenbaum, Jérémie Sellam, Alice Courties	4
4	Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study 2019 ·BMJ ·Jacques‐Eric Gottenberg, Jacques Morel, Élodie Perrodeau, Thomas Bardin, Bernard Combe, Maxime Dougados, René‐Marc Flipo, Alain Saraux, Thierry Schaeverbeke, Jean Sibilia, Martin Soubrier, Olivier Vittecoq, Gabriel Baron, Arnaud Constantin, Philippe Ravaud, Xavier Mariette	93
5	Effect of Gut Involvement in Patients with High Probability of Early Spondyloarthritis: Data from the DESIR Cohort 2019 ·The Journal of Rheumatology ·Daniel Wendling, Xavier Guillot, Clément Prati, Corinne Miceli‐Richard, Anna Moltó, Rik Lories, Maxime Dougados	8
6	Rheumatology training experience across Europe: analysis of core competences 2016 ·Arthritis Research & Therapy ·(unknown), Francisca Sivera, Sofía Ramiro, Nada Čikeš, Maurizio Cutolo, Maxime Dougados, Laure Gossec, Tore K Kvien, Ingrid E. Lundberg, Péter Mandl, Arumugam Moorthy, Sonia Panchal, José António Pereira da Silva, J. W. J. Bijlsma	15
7	SUSTAINED EFFICACY OF ADALIMUMAB IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WITH POSITIVE MRI OF THE SACROILIAC JOINTS OR SPINE OR ELEVATED C-REACTIVE PROTEIN AT BASELINE 2013 ·Lara D. Veeken ·J. Sieper, Désirée van der Heijde, Maxime Dougados, Filip Van den Bosch, P. Goupille, Suchitrita S. Rathmann, (unknown)	1
8	GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate 2013 ·Lara D. Veeken ·Isabel Castrejón, Theodore Pincus, Martin Soubrier, Yih Chang Lin, (unknown), Bernard Combe, Maxime Dougados	12
9	Efficacy and Safety of Certolizumab Pegol in a Broad Population of Patients with Active Rheumatoid Arthritis: Week 28 Results From a Phase IIIb Randomized Controlled Study 2011 ·Data Archiving and Networked Services (DANS) ·M. Weinblatt, R Fleischmann, Ronald van Vollenhoven, P. Emery, T. Huizinga, (unknown), (unknown), Benjamin Duncan, O. Davies, Maxime Dougados	2
10	Spondyloarthritis breakdown → 2011 ·The Lancet ·Maxime Dougados, Dominique Baeten	574
11	Arthritis 2 Spondyloarthritis 2011 ·The Lancet ·Maxime Dougados, Dominique Baeten	307
12	Efficacy and Safety of Adalimumab in Patients with Non-Radiographic Axial Spondyloarthritis - Results From a Phase 3 Study 2011 ·Data Archiving and Networked Services (DANS) ·J. Sieper, Désirée van der Heijde, Maxime Dougados, Philip J. Mease, (unknown), (unknown)	6
13	Relative Clinical Influence of Clinical, Laboratory, and Radiological Investigations in Early Arthritis on the Diagnosis of Rheumatoid Arthritis. Data from the French Early Arthritis Cohort ESPOIR 2010 ·The Journal of Rheumatology ·Laure Gossec, Christophe Combescure, Nathalie Rincheval, Alain Saraux, Bernard Combe, Maxime Dougados	21
14	289 MAGNITUDE OF THE SYMPTOMATIC AT 3, 6 AND 12 MONTHS AFTER TOTAL ARTICULAR REPLACEMENT IN HIP AND KNEE OSTEOARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS 2008 ·Osteoarthritis and Cartilage ·J. Fernández-Lopez, Laure Gossec, Maxime Dougados	1
15	Characterization and Functional Consequences of Underexpression of Clusterin in Rheumatoid Arthritis 2006 ·The Journal of Immunology ·Valérie Devauchelle, (unknown), Gonzague de Pinieux, Stéphane Germain, Léa Tourneur, Sylvie Mistou, Florence Margottin-Goguet, Philippe Anract, Henri Migаud, D. Le Nen, Thierry Lequerré, Alain Saraux, Maxime Dougados, Maxime Bréban, Catherine Fournier, Gilles Chiocchia	69
16	Reproducibility and sensitivity to change of various methods of joint space width (JSW) measurements in osteoarthritis of the hip (OAH). A double reading of three different radiographic views taken within a 3-year time-interval. 2005 ·Annals of the Rheumatic Diseases ·E. Maheu, C. Cadet, (unknown), (unknown), (unknown), B Mazières, Tim D. Spector, E. Vignon, Maxime Dougados, M Lequesne	10
17	Reproducibility and sensitivity to change of various methods to measure joint space width in osteoarthritis of the hip: a double reading of three different radiographic views taken with a three-year interval 2005 ·Arthritis Research & Therapy ·E. Maheu, C. Cadet, Marc Marty, Maxime Dougados, (unknown), (unknown), Bernard Mazières, Tim D. Spector, Éric Vignon, Michel Lequesne	33
18	Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis 2003 ·Queensland's institutional digital repository (The University of Queensland) ·Florence Tubach, Gabriel Baron, Philippe Ravaud, Bruno Falissard, I. Logeart, (unknown), David T. Felson, D. van der Heijde, M. Hochberg, N. Bellamy, Maxime Dougados	5
19	Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group 2003 ·Annals of the Rheumatic Diseases ·Thao Pham, Désirée van der Heijde, Andrei Călin, Muhammad Asim Khan, Sj. van der Linden, Nicholas Bellamy, Maxime Dougados	23
20	Tiludronate and etidronate in Paget's disease of bone: a comparative prospective double-blind multicenter study 1994 ·Open Repository and Bibliography (University of Liège) ·C. Roux, C. Gennari, (unknown), JP Devogelaer, Hindrik Mulder, (unknown), (unknown), (unknown), Jean‐Yves Reginster, Maxime Dougados	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact